ANAPLASTIC ASTROCYTOMA (AOA)
1 clinical trials · Condition
◉ Watch ANAPLASTIC ASTROCYTOMA (AOA)
| Record | Firm | Date |
|---|---|---|
| Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA (NCT01238237) | Northwell Health | 2009-12-01 |
Track ANAPLASTIC ASTROCYTOMA (AOA) automatically
Every clearance here is in the API, with alerts when new ones post.